Caplin Point Laboratories Ltd - 524742 - Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPS
INTIMATION OF ALLOTMENT OF EQUITY SHARES UNDER EMPLOYEE STOCK OPTION PLAN -2015.31-05-2019
31-05-2019
CAPLIN POINT LABORATORIES LTD. - 524742 - Reg.24(A)-Annual Secretarial Compliance
Annual Secretarial Compliance Report Sr. No. Particulars Details 1Period for which the report has been issued 31/03/2019 2Date of Report27/05/2019 3 Name of the Certifying Firm G RAMACHANDRAN & ASSOCIATES 4 Name of the Certifying Individual G RAMACHANDRAN 5Membership TypeFCS 6 Membership Number 9687 7 CP No. 3056 8 Whether any observations/qualification reported by the Secretarial Auditor ? NO28-05-2019
Caplin Point Laboratories Ltd - 524742 - Format of Initial Disclosure to be made by an entity identified as a Large Corporate
Format of Initial Disclosure to be made by an entity identified as a Large Corporate. Sr. No. Particulars Details 1Name of CompayCAPLIN POINT LABORATORIES LTD. 2CINL24231TN1990PLC019053 3 Outstanding borrowing of company as on 31st March / 31st December, as applicable (in Rs cr) 0.00 4Highest Credit Rating during the previous FY NIL 4aName of the Credit Rating Agency issuing the Credit Rating mentioned in (4)Not Applicable 5Name of Stock Exchange# in which the fine shall be paid, in case of shortfall in the required borrowing under the frameworkBSE We confirm that we are a Large Corporate as per the applicability criteria given under the SEBI circular SEBI/HO/DDHS/CIR/P/2018/144 dated November 26, 2018. No Name of the Company Secretary: VINODKUMARS Designation: COMPANYSECRETARY EmailId: vinodkumar@caplinpoint.net Name of the Chief Financial Officer: DMURALIDHARAN Designation: CHIEFFINANCIALOFFICER EmailId: dmuralidharan@caplinpoint.net Date: 27/05/2019 Note: In terms para of 3.2(ii) of the circular, beginning F.Y 2022, in the event of shortfall in the mandatory borrowing through debt securities, a fine of 0.2% of the shortfall shall be levied by Stock Exchanges at the end of the two-year block period. Therefore, an entity identified as LC shall provide, in its initial disclosure for a financial year, the name of Stock Exchange to which it would pay the fine in case of shortfall in the mandatory borrowing through debt markets.27-05-2019
Caplin Point Laboratories Ltd - 524742 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
COMPLIANCE UNDER REGULATION 39(3) OF SEBI (LISTING OBLIGATIONS AND DISCLOSURE REQUIREMENTS) REGULATIONS, 201523-05-2019
CAPLIN POINT LABORATORIES LTD. - 524742 - Board recommends Dividend
Caplin Point Laboratories Ltd has informed BSE that the Board of Directors of the Company at its Meeting held on May 22, 2019, inter alia, has recommended a dividend of Rs. 2.20 (110%) per equity share of Rs. 2/- each for the financial year ended March 31, 2019.22-05-2019
CAPLIN POINT LABORATORIES LTD. - 524742 - AUDITED FINANCIAL RESULTS FOR THE QUARTER AND YEAR ENDED MARCH 31,2019
AUDITED FINANCIAL RESULTS FOR THE QUARTER AND YEAR ENDED MARCH 31,2019 AND RECOMMENDATION OF DIVIDEND FOR THE YEAR ENDED MARCH 31,2019.22-05-2019
Caplin Point Laboratories Ltd - 524742 - Board to consider Dividend
Caplin Point Laboratories Ltd has informed BSE that a meeting of the Board of Directors of the Company will be held on May 22, 2019, inter alia, to consider the following;1. To consider and approve the Audited Financial Results for quarter/ year ended March 31, 2019.2. Recommendation of Dividend for the financial year ended March 31, 2019.Further to our letter dated April 05, 2019, the Trading Window for dealing in the equity shares of the Company shall remain closed for Promoters, Directors, other Connected Persons and Employees of the Company from April 05, 2019 to May 24, 2019 (both days inclusive ) as per the Company's Code of Conduct to regulate, monitor and report trading by insiders adopted by the Board pursuant to SEBl (Prohibition of Insider Trading) Regulations, 2015.14-05-2019
Caplin Point Laboratories Ltd - 524742 - Board Meeting Intimation for Considering The Audited Financial Results For The Quarter/ Year Ended March 31, 2019.
CAPLIN POINT LABORATORIES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 22/05/2019 ,inter alia, to consider and approve the Audited Financial Results for quarter/ year ended March 31, 2019 and recommendation of Dividend for the financial year ended March 31, 2019.14-05-2019
CAPLIN POINT LABORATORIES LTD. - 524742 - Announcement under Regulation 30 (LODR)-Press Release / Media Release
CAPLIN POINT GETS COLOMBIA APPROVAL FOR STERILE INJECTABLES13-05-2019